VTE and the Related Factors Associated With Higher Rates of PE After a DVT in Southwestern China
NCT05464901 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2022-07-19
Summary
Little is known about the current management status of venous thromboembolism (VTE) in Southwestern China. We aimed to investigate the status of anticoagulant administration in VTE in Southwestern China and assess the potential predictors of deep vein thrombosis (DVT) complicated pulmonary embolism (PE). We extracted data from YiduCloud database from December 2006 to November 2018 and performed a cross-sectional survey of VTE. The demographics, laboratory tests, and anticoagulants were collected and analyzed in the logistic regression model, classification tree and Random Forest model.
Conditions
- Venous Thromboembolism; Deep Vein Thrombosis; Pulmonary Embolism; Anticoagulants
Sponsors & Collaborators
-
Wei Huang
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-12-01
- Primary Completion
- 2018-07-01
- Completion
- 2018-11-01
More Related Trials
-
Predicting the Risk of Venous Thromboembolism in Critically Ill Patients
NCT05498142 ·Status: UNKNOWN
-
A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients
NCT02213978 ·Status: COMPLETED
-
Six Years of Follow-up After Idiopathic Venous Throbmoembolism
NCT02884934 ·Status: COMPLETED
-
Evaluation of the Predictive Value of the Microvesicle Coagulo-lytic Balance in the Recurrence of Venous Thrombosis
NCT03265054 ·Status: UNKNOWN
-
Venous Thromboembolism Prophylaxis in Medical and Surgical ICUs in a Single University Hospital
NCT01851239 ·Status: COMPLETED
-
A Prospective Study in Chinese Patients With Lower Extremity Ankle Fracture of Oral Anticoagulants to Prevent Venous Thromboembolism (VTE)
NCT04128254 ·Status: UNKNOWN ·Phase: PHASE4
-
Risk of Recurrent Venous Thromboembolism After Provoked Venous Thromboembolism
NCT04124159 ·Status: UNKNOWN
-
Personalized Anticoagulant Therapy for Pulmonary Thromboembolism
NCT06341231 ·Status: RECRUITING
-
Risk Factors for Venous Thromboembolism
NCT00018772 ·Status: COMPLETED
-
Long-term Surveillance of Patients With Venous Thromboembolism: a Nationwide Prospective Cohort Study
NCT06073366 ·Status: COMPLETED
-
Risk Factors and Prediction Model of Cancer-associated Venous Thromboembolism
NCT05729464 ·Status: UNKNOWN
-
Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test.
NCT04710732 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients
NCT00810784 ·Status: COMPLETED
-
Nadroparin for the Initial Treatment of Pulmonary Thromboembolism
NCT00796692 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness
NCT05819112 ·Status: TERMINATED
-
Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized Patients
NCT05515549 ·Status: UNKNOWN
-
Extended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against DVT and PE in Patients Undergoing Major Lung Resection
NCT02258958 ·Status: COMPLETED
-
Epidemiology of Venous Thromboembolism
NCT00456196 ·Status: COMPLETED
-
Mechanical Thrombectomy for Acute Lower Limb Deep Vein Thrombosis in Tumor Patients
NCT06085495 ·Status: COMPLETED ·Phase: NA
-
Prolonged Anticoagulation Therapy on the Prognosis of Patients With Left Ventricular Thrombosis
NCT06209892 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Appropriate Anticoagulation Duration for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism
NCT03185845 ·Status: UNKNOWN ·Phase: NA
-
Description of Patients With Acute Venous Thromboembolism in the UK's Clinical Practice Research Datalink Linked With Hospital Episode Statistics Dataset (CPRD-HES)
NCT02661568 ·Status: COMPLETED
-
Catheter-interventional Treatment of Pulmonary Embolism
NCT05456789 ·Status: COMPLETED ·Phase: NA
-
Pradaxa or Warfarin for Prevention of Recurrent VTE in Patients With Angiographically Confirmed Acute Massive Pulmonary Embolism undergoIng Endovascular Mechanical Fragmentation and Thrombolytic Therapy
NCT02979561 ·Status: UNKNOWN ·Phase: PHASE4
-
Cohort for Monitoring Patients With Venous Thromboembolic Disease
NCT07016542 ·Status: RECRUITING